LONDON (Reuters) - Britain's antitrust watchdog said on Friday that GlaxoSmithKline and three generic drug companies had undermined competition by striking deals that paid the generic firms not to launch cheap copies of the antidepressant paroxetine.
via Reuters: Health News Read More Here..
No comments:
Post a Comment